Detalhe da pesquisa
1.
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.
Nature
; 548(7666): 234-238, 2017 08 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28783719
2.
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors.
Invest New Drugs
; 39(6): 1577-1586, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34180036
3.
Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival.
J Neurooncol
; 146(1): 163-170, 2020 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-31823165
4.
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Lancet Oncol
; 20(9): 1263-1272, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31331699
5.
MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer.
Int J Cancer
; 145(3): 748-762, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30694565
6.
Proof of the quantitative potential of immunofluorescence by mass spectrometry.
Lab Invest
; 97(3): 329-334, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28092364
7.
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
Cancer
; 123(6): 1061-1070, 2017 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27926778
8.
Targeting the hepatocyte growth factor/Met pathway in cancer.
Biochem Soc Trans
; 45(4): 855-870, 2017 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28673936
9.
Therapeutically Induced Changes in HER2, HER3, and EGFR Protein Expression for Treatment Guidance.
J Natl Compr Canc Netw
; 14(5): 503-7, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27160229
10.
Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.
Gastric Cancer
; 19(4): 1066-1079, 2016 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26581548
11.
Imaging the Met Receptor Tyrosine Kinase (Met) and Assessing Tumor Responses to a Met Tyrosine Kinase Inhibitor in Human Xenograft Mouse Models with a [99mTc] (AH-113018) or Cy 5** (AH-112543) Labeled Peptide.
Mol Imaging
; 14: 499-515, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26461980
12.
Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.
J Transl Med
; 12: 199, 2014 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25335552
13.
HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer.
Sci Rep
; 14(1): 12129, 2024 05 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38802399
14.
Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling.
Cancers (Basel)
; 15(2)2023 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36672409
15.
The addition of FAIMS increases targeted proteomics sensitivity from FFPE tumor biopsies.
Sci Rep
; 12(1): 13876, 2022 08 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35974054
16.
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
PLoS One
; 17(10): e0276211, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36215283
17.
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling.
Front Oncol
; 12: 964219, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36578937
18.
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
PLoS One
; 16(12): e0261994, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34941969
19.
MET Exon 14-altered Lung Cancers and MET Inhibitor Resistance.
Clin Cancer Res
; 27(3): 799-806, 2021 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33172896
20.
Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S.
Tumori
; 107(2): 150-159, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32522106